| Bioactivity | HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor[1]. |
| Invitro | HCV Peptide (35-44) (0-100 μM) 抑制总 NK 细胞群的脱颗粒。 HCV 肽 (35-44) 增加 HLA-C 和 HLA-E 的细胞表面表达[1]。 |
| Name | HCV Peptide (35-44) |
| CAS | 160214-01-7 |
| Shortening | YLLPRRGPRL |
| Formula | C57H97N19O12 |
| Molar Mass | 1240.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
HCV Peptide (35-44)
CAS: 160214-01-7 F: C57H97N19O12 W: 1240.50
HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) i
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.